ATE346168T1 - Funktionelles oberflächendisplay von polypeptiden - Google Patents

Funktionelles oberflächendisplay von polypeptiden

Info

Publication number
ATE346168T1
ATE346168T1 AT02718168T AT02718168T ATE346168T1 AT E346168 T1 ATE346168 T1 AT E346168T1 AT 02718168 T AT02718168 T AT 02718168T AT 02718168 T AT02718168 T AT 02718168T AT E346168 T1 ATE346168 T1 AT E346168T1
Authority
AT
Austria
Prior art keywords
polypeptides
surface display
functional surface
display
autotransporter
Prior art date
Application number
AT02718168T
Other languages
English (en)
Inventor
Joachim Jose
Franck Hannemann
Rita Bernhardt
Original Assignee
Univ Des Saarlandes Wissens Un
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Des Saarlandes Wissens Un filed Critical Univ Des Saarlandes Wissens Un
Application granted granted Critical
Publication of ATE346168T1 publication Critical patent/ATE346168T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Materials For Medical Uses (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
AT02718168T 2001-03-02 2002-03-01 Funktionelles oberflächendisplay von polypeptiden ATE346168T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01105129 2001-03-02

Publications (1)

Publication Number Publication Date
ATE346168T1 true ATE346168T1 (de) 2006-12-15

Family

ID=8176655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02718168T ATE346168T1 (de) 2001-03-02 2002-03-01 Funktionelles oberflächendisplay von polypeptiden

Country Status (7)

Country Link
US (1) US20040259151A1 (de)
EP (1) EP1373571B1 (de)
AT (1) ATE346168T1 (de)
AU (1) AU2002249249A1 (de)
DE (1) DE60216245T2 (de)
DK (1) DK1373571T3 (de)
WO (1) WO2002070645A2 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004065415A2 (en) 2003-01-20 2004-08-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. L-amino acid oxidase with cytotoxic activity from aplysia punctata
US7253293B2 (en) * 2004-01-06 2007-08-07 Andrzej Slominski Enzymatic method to produce 7-dehydropregnenolone, vitamin D3-like compounds and derivatives thereof
WO2006015445A1 (en) 2004-08-13 2006-02-16 Marshall Barry J Bacterial delivery system
US8029777B2 (en) 2004-08-13 2011-10-04 Marshall Barry J Helicobacter system and uses thereof
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
NZ584162A (en) * 2007-10-04 2012-05-25 Bio Architecture Lab Inc Biofuel production
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
DE102010035702A1 (de) * 2010-08-27 2012-03-01 Zyrus Beteiligungsgesellschaft Mbh & Co. Patente I Kg Ganzzell-Biokatalysator
WO2012038508A1 (en) * 2010-09-23 2012-03-29 Autodisplay Biotech Gmbh Surface display of polypeptides containing a metal porphyrin or a flavin
CN103228787B (zh) 2010-09-28 2017-06-23 阿贝拉生物科学公司 用于分泌性蛋白表达的融合蛋白
EP3527222B1 (de) * 2011-02-15 2021-04-07 Vaxiion Therapeutics, LLC Therapeutische zusammensetzungen und verfahren für auf antikörper- und fc-haltigen molekülen basierende gezielte verabreichung bioaktiver moleküle durch bakterienminizellen
WO2012152923A1 (en) * 2011-05-12 2012-11-15 Autodisplay Biotech Gmbh Whole cell biocatalyst comprising a prenyltransferase
CA2842000A1 (en) 2011-07-20 2013-01-24 Evonik Degussa Gmbh Oxidation and amination of primary alcohols
JP2014524245A (ja) 2011-08-05 2014-09-22 エボニック デグサ ゲーエムベーハー 二級アルコールの酸化及びアミン化
EP2602329A1 (de) 2011-12-05 2013-06-12 Evonik Degussa GmbH Biotechnologische Herstellung von 3-Hydroxyisobuttersäure
EP2602328A1 (de) 2011-12-05 2013-06-12 Evonik Industries AG Verfahren zur Oxidation von Alkanen unter Verwendung einer AlkB Alkan 1-Monooxygenase
EP2639308A1 (de) 2012-03-12 2013-09-18 Evonik Industries AG Enzymatische omega-Oxidation und -Aminierung von Fettsäuren
EP2653538A1 (de) 2012-04-20 2013-10-23 Evonik Industries AG NADP-abhängige Alanindehydrogenase
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
WO2014139862A1 (en) * 2013-03-13 2014-09-18 Autodisplay Biotech Gmbh Improved surface display of functional proteins in a broad range of gram negative bacteria
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344350C2 (de) * 1993-12-23 1995-09-21 Max Planck Gesellschaft Bakterien zur Herstellung stabiler Fusionsproteine und Verfahren zu deren Nachweis
US6686168B1 (en) * 1999-11-04 2004-02-03 Zymogenetics, Inc. Cell surface display of proteins by recombinant host cells

Also Published As

Publication number Publication date
DK1373571T3 (da) 2007-04-16
WO2002070645A2 (en) 2002-09-12
EP1373571A2 (de) 2004-01-02
DE60216245D1 (de) 2007-01-04
AU2002249249A1 (en) 2002-09-19
EP1373571B1 (de) 2006-11-22
DE60216245T2 (de) 2007-06-21
US20040259151A1 (en) 2004-12-23
WO2002070645A3 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
ATE346168T1 (de) Funktionelles oberflächendisplay von polypeptiden
DE60041505D1 (de) Inzektizide proteinen von bacillus thuringiensis
DE69823046D1 (de) Praktische in vitro sialylierung von rekombinanten glykpproteinen
DE60141546D1 (de) Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
ATE227739T1 (de) Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
DE69731226D1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
DE69812773D1 (de) Methode zur de novo Peptidsequenz-Bestimmung
ATE454393T1 (de) Egvii-endoglucanase und dafür codierende nukleinsäuren
DE60111236D1 (de) Hybriden von crystal proteinen aus bacillus thurigiensis
DE69831777D1 (de) Framework zur finanziellen Integration von Geschäftsapplikationen
ATE490323T1 (de) Adiponektin-rezeptor und dafür kodierendes gen
FI943389A (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
DE60207053D1 (de) Rekombinante gelatineartige proteine zur verwendung als plasmaexpander
DE69823525D1 (de) Verfahren zur hochauflösenden identifizierung von lösungsmittel-zugänglichen amidhydrogenen in polypeptiden
BR0311318A (pt) Inibidores de peptìdeo desformilase
ATE323763T1 (de) Dna & protein bindende miniatur proteine
DE60238449D1 (de) Nukleinsäuren, polypeptide und verfahren zur apoptosemodulation
DE60026774D1 (de) Defekterkennung mit Verwendung von Grauwertsignaturen
NO972063L (no) Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle
DK0826054T3 (da) Ekspression af glycosyltransferase i Aspergillus
DE60210970D1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
DE60334316D1 (de) Frpb proteinmutante und verfahren zur erneuten faltung
ATE379816T1 (de) Architektur zum verarbeiten von fingerabdruckbildern
DE60314890D1 (de) Verfahren zur leitweglenkung von datenpaketen, und vorrichtungen zur implementierung dieses verfahrens
DE59807751D1 (de) Verfahren zur beschichtung von siliconelastomeren

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1373571

Country of ref document: EP

EEIH Change in the person of patent owner